Versant Venture Capital VI, L.P. - Insider Trading & Ownership
-
Entity
-
Company
-
Location
-
One Sansome Street, Suite 1650, San Francisco, CA
-
Summary
-
The estimated value of insider holdings of Versant Venture Capital VI, L.P. is at least $124M dollars as of October 30, 2024. Versant Venture Capital VI, L.P. is the 10%+ Owner of Monte Rosa Therapeutics, Inc. and owns shares of Monte Rosa Therapeutics, Inc. (GLUE) stock worth about $53.2M. Versant Venture Capital VI, L.P. is the 10%+ Owner of Black Diamond Therapeutics, Inc. and owns shares of Black Diamond Therapeutics, Inc. (BDTX) stock worth about $28.7M. Versant Venture Capital VI, L.P. is the 10%+ Owner of Century Therapeutics, Inc. and owns shares of Century Therapeutics, Inc. (IPSC) stock worth about $18.1M. Versant Venture Capital VI, L.P. is the 10%+ Owner of LENZ Therapeutics, Inc. and owns shares of LENZ Therapeutics, Inc. (LENZ) stock worth about $12M. Versant Venture Capital VI, L.P. is the 10%+ Owner of Contineum Therapeutics, Inc. and owns shares of Contineum Therapeutics, Inc. (CTNM) stock worth about $8.93M. Versant Venture Capital VI, L.P. is the 10%+ Owner of Tempest Therapeutics, Inc. and owns shares of Tempest Therapeutics, Inc. (TPST) stock worth about $2.56M.